Literature DB >> 31240635

Impact of dyslipidemia on estimated glomerular filtration rate in apparently healthy children and adolescents: the CASPIAN-V study.

Mohammad Moafi1, Farahnak Assadi2, Ramin Heshmat3, Mehri Khoshhali4, Mostafa Qorbani5, Mohammad E Motlagh6, Razieh Dashti7, Majzoubeh Taheri8, Roya Kelishadi9.   

Abstract

BACKGROUND: Chronic kidney disease (CKD) is a leading risk factor for development of cardiovascular disease (CVD). Dyslipidemia is also known as risk factor for CVD development. However, the association of dyslipidemia with glomerular injury among healthy children and adolescents remains controversial. We aimed to investigate the relationship between estimated glomerular filtration rate (eGFR) and lipid profile risk factors among healthy children and adolescents.
METHODS: In this nationwide survey, 3808 participants (1992 males, 1816 females), aged 7-18 years, were selected by cluster random sampling method from 30 provinces in Iran. Body mass index (BMI) and systolic and diastolic blood pressures were measured. Blood samples were obtained for serum creatinine, fasting blood glucose, total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglyceride (TG) determinations. GFR was estimated using Schwartz equation.
RESULTS: Girls had higher eGFR than boys (P = 0.04). In a multiple regression analysis, eGFR demonstrated a positive correlation with systolic blood pressure, BMI, fasting glucose, TC, HDL-C, and TG. By the analysis of covariance, TC, HDL-C, and TG showed a negative correlation with eGFR after adjustments for BMI, systolic and diastolic blood pressures, and fasting glucose (OR = 0.56, 95% CI = 0.29-0.89).
CONCLUSION: The study showed that dyslipidemia is associated with reduced eGFR among the healthy children and adolescents.

Entities:  

Keywords:  Adolescents; Children; Dyslipidemia; Estimated glomerular filtration rate

Mesh:

Substances:

Year:  2019        PMID: 31240635     DOI: 10.1007/s12519-019-00270-2

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  30 in total

1.  Lipoprotein [a] is cleared from the plasma primarily by the liver in a process mediated by apolipoprotein [a].

Authors:  William J Cain; John S Millar; Adam S Himebauch; Uwe J F Tietge; Cyrille Maugeais; David Usher; Daniel J Rader
Journal:  J Lipid Res       Date:  2005-09-08       Impact factor: 5.922

2.  Association of anthropometric measures and cardio-metabolic risk factors in normal-weight children and adolescents: the CASPIAN-V study.

Authors:  Zeinab Ahadi; Maryam Bahreynian; Mostafa Qorbani; Ramin Heshmat; Mohammad Esmaeil Motlagh; Gita Shafiee; Armita Mahdavi Gorabi; Hasan Ziaodini; Majzoubeh Taheri; Tahereh Aminaei; Roya Kelishadi
Journal:  J Pediatr Endocrinol Metab       Date:  2018-08-28       Impact factor: 1.634

Review 3.  New perspectives on CKD-induced dyslipidemia.

Authors:  Marcelino Bermúdez-López; David Arroyo; Àngels Betriu; Luis Masana; Elvira Fernández; Jose M Valdivielso
Journal:  Expert Opin Ther Targets       Date:  2017-08-28       Impact factor: 6.902

Review 4.  Cardiovascular Disease in Children and Adolescents With Chronic Kidney Disease.

Authors:  Donald J Weaver; Mark Mitsnefes
Journal:  Semin Nephrol       Date:  2018-11       Impact factor: 5.299

5.  Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial.

Authors:  Lawrence J Appel; Catherine M Champagne; David W Harsha; Lawton S Cooper; Eva Obarzanek; Patricia J Elmer; Victor J Stevens; William M Vollmer; Pao-Hwa Lin; Laura P Svetkey; Sarah W Stedman; Deborah R Young
Journal:  JAMA       Date:  2003 Apr 23-30       Impact factor: 56.272

6.  Impact of low-density lipoprotein cholesterol on decline in estimated glomerular filtration rate in apparently healthy young to middle-aged working men.

Authors:  Akihiro Kuma; Bungo Uchino; Yoko Ochiai; Masatoshi Kawashima; Kazuhiko Enta; Masahito Tamura; Yutaka Otsuji; Akihiko Kato
Journal:  Clin Exp Nephrol       Date:  2017-04-06       Impact factor: 2.801

7.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.

Authors:  Paul S Jellinger; Yehuda Handelsman; Paul D Rosenblit; Zachary T Bloomgarden; Vivian A Fonseca; Alan J Garber; George Grunberger; Chris K Guerin; David S H Bell; Jeffrey I Mechanick; Rachel Pessah-Pollack; Kathleen Wyne; Donald Smith; Eliot A Brinton; Sergio Fazio; Michael Davidson
Journal:  Endocr Pract       Date:  2017-04       Impact factor: 3.443

8.  Effects of lowering LDL cholesterol on progression of kidney disease.

Authors:  Richard Haynes; David Lewis; Jonathan Emberson; Christina Reith; Lawrence Agodoa; Alan Cass; Jonathan C Craig; Dick de Zeeuw; Bo Feldt-Rasmussen; Bengt Fellström; Adeera Levin; David C Wheeler; Rob Walker; William G Herrington; Colin Baigent; Martin J Landray
Journal:  J Am Soc Nephrol       Date:  2014-05-01       Impact factor: 10.121

Review 9.  A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010.

Authors:  Katherine T Mills; Yu Xu; Weidong Zhang; Joshua D Bundy; Chung-Shiuan Chen; Tanika N Kelly; Jing Chen; Jiang He
Journal:  Kidney Int       Date:  2015-07-29       Impact factor: 10.612

10.  Effect of Statins on Renal Function in Chronic Kidney Disease Patients.

Authors:  Ping-Jen Hu; Mei-Yi Wu; Tsu-Chen Lin; Tzu-Ting Chen; Yun-Chun Wu; Sui-Lung Su; Kuo-Cheng Lu; Jin-Shuen Chen; Fung-Chang Sung; Chien-Te Lee; Yu Yang; Shang-Jyh Hwang; Ming-Cheng Wang; Yung-Ho Hsu; Hung-Yi Chiou; Chung-Shun Wong; Yuh-Feng Lin
Journal:  Sci Rep       Date:  2018-11-02       Impact factor: 4.379

View more
  2 in total

1.  The association between dyslipidemia and the incidence of chronic kidney disease in the general Zhejiang population: a retrospective study.

Authors:  Xudong Liang; Meiyu Ye; Mei Tao; Danna Zheng; Ruyi Cai; Yifan Zhu; Juan Jin; Qiang He
Journal:  BMC Nephrol       Date:  2020-07-02       Impact factor: 2.388

2.  Association of Lipid Parameters with the Risk of Chronic Kidney Disease: A Longitudinal Study Based on Populations in Southern China.

Authors:  Xin Wang; Haishan Chen; Xiaofei Shao; Chongxiang Xiong; Guobao Hong; Jianhui Chen; Xiaolin Li; Xu You; Peichun Gao; Yunying Chen; Ziliang Zou; Jing Ning; Hua Xiao; Hequn Zou; Lixin Wei
Journal:  Diabetes Metab Syndr Obes       Date:  2020-03-04       Impact factor: 3.168

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.